Enliven Therapeutics Inc

NASDAQ:ELVN   4:00:00 PM EDT
27.45
-0.08 (-0.29%)
: $26.67 -0.78 (-2.84%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Enliven Therapeutics Inc Stock, NASDAQ:ELVN

6200 Lookout Road, Suite 300, Boulder, Colorado 80301
United States of America
Phone: +1.720.647.8519
Number of Employees: 46
http://www.enliventherapeutics.com

Description

Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates. The company was founded by Sam S. Kintz, Joe P. Lyssikatos, and Anish Patel in June 2019 and is headquartered in Boulder, CO.